A 40-year-old female presented with cough, exertional dyspnea, abdominal pain with distention, fatigue, dry eyes and dry mouth. Past history revealed asthma. Physical examination was normal except for tachypnea. We found leukocytosis, azygos fissure on chest X-ray along with normal pulmonary function tests and arterial blood gases. Thorax computed tomography (CT) revealed bronchiectasis and ground glass opacities in both lungs. Abdominal CT demonstrated thrombosed proximal splenic artery aneurysm. Further diagnostic procedures were done and according to the positive Schirmer test and compatible histopathologic findings of the salivary gland, diagnosis of primary Sjögren's syndrome was established. Splenic artery aneurysm is rare occurring in less than 1% of the population that usually appears as an incidental finding. This is the first case in literature that introduces Sjögren's syndrome as a risk factor for splenic artery aneurysm. The silent presentation of the splenic artery aneurysm should previse the clinicians that such an occurrence may cause a significant diagnostic dilemma.
Introduction
Aneurysm of the splenic artery is very rare while it is the most frequent site for visceral arterial aneurysms [1] [2] [3] . Rupture carries a substantial mortality risk and a severe outcome may come out as the initial manifestation [4, 5] . Most of the splenic artery aneurysms are clinically silent and are incidentally diagnosed. Fatal complications may occur if the diagnosis is delayed. The clinical presentation and the laboratory findings were not suggestive for a splenic artery aneurysm diagnosis in our case. On the other hand, Sjögren's syndrome is a chronic autoimmune disease with exocrine gland dysfunction as a result of lymphocytic infiltration that may lead to arterial aneurysms. Although various arterial aneurysms have been described in Sjögren's syndrome, splenic artery aneurysm due to this syndrome has not been reported previously [6] [7] [8] [9] [10] . We present this patient as it is the first splenic artery aneurysm case in the literature associated with the Sjögren's syndrome. Second, its silent atypical profile may evoke a diagnostic impasse for the clinicians.
Case report
A 40-year-old female was admitted for cough, exertional dyspnea, abdominal pain with distension in the left upper quadrant, fatigue, dry eyes and a dry mouth for nine months. Dyspnea had deteriorated in the last six weeks. The patient was a non-smoker. Past history revealed asthma, one abortus, one curettage and two children. Her mother died of myocardial infarction while her father had diabetes mellitus, hypertension and stroke. Physical examination did not reveal any abnormal findings except for a tachypnea of 20 3.40 ml/mmHg/min/l (predicted: 5.69; 60%). Bronchoscopic examination was normal and BAL cytology revealed lymphocytic alveolitis. Immunology testing was done. Antinuclear antibody (ANA) and rheumatoid factor (RF) were positive while all other antibodies remained negative. RF was 24.4 IU/ml and ANA was 1/2560 IU/ml with a speckled pattern. Abdominal CT revealed a saccular aneurysm of the partially thrombosed 18 mm splenic artery (Figure 4) , while abdominal ultrasound, CT and gastrointestinal endoscopy performed for pain with distention two years ago revealed normal findings. Schirmer test was positive with a 0 mm strip paper result that indicated xerophthalmia. Histopathologic examination of the salivary gland revealed extensive lymphoid infiltrates with germinal centers, limited interstitial fibrosis and acinar atrophy. Rheumatology consultation identified the Sjögren's syndrome in the patient. The final diagnosis was splenic artery aneurysm associated with Sjögren's syndrome. The patient is currently under conservative management with CT follow-up every six months.
Discussion
Sjögren's syndrome is a relatively common autoimmune disorder affecting 2-3% of the adult population. It is characterized by lymphocytic infiltration and destruction of the exocrine glands. The salivary and lacrimal glands are primarily affected, leading to a dry mouth and dry eyes, as the hallmark of the disease. Other exocrine glands, which may be affected, include those of the pancreas, bronchial tree and gastrointestinal tract. Sjögren's syndrome may occur as primary or in association with other connective tissue diseases as secondary. The spectrum of clinical manifestations of Sjögren's syndrome is wide ranging from mucosal dryness directly relevant to exocrine dysfunction to more systemic complaints affecting mainly the musculoskeletal, pulmonary, renal and vascular systems. Almost half of the highly selected Sjögren's syndrome patients with active CNS disease have small vessel vasculitis such as stenosis, aneurysm or occlusion of the small cerebral blood vessels [11] [12] [13] [14] [15] . Splenic artery aneurysm is the most common among visceral arterial aneurysms that constitute 60% of similar lesions [16] . Exact prevalence is unknown as most of these aneurysms have a silent clinical profile and are asymptomatic. Autopsy studies reveal a prevalence between 0.01% and 10.4% while they are identified coincidentally on 0.78% of the angiograms [2, 17, 18] . The asymptomatic clinical course and the lack of clinical suspicion may lead to a fatal outcome that may be as high as 70% to 90% due to the lethal consequences of a ruptured splenic artery aneurysm [19] . As arterial aneurysms of different locations are a known feature of Sjögren's syndrome, our case is unique for its presentation with a splenic artery aneurysm as the first patient in literature.
The only symptom of our patient was abdominal pain with distention that may be poorly attributed to the splenic artery aneurysm and easily go unnoticed while the final diagnosis was reached by performing almost an incidental abdominal CT due to this nonspecific manifestation. Dryness of the pharynx and esophagus due to lack of saliva along with impaired gastric emptying in primary Sjögren's syndrome may lead to deglutition, impaired clearance of acid, gastroesophageal reflux and esophagitis [20] [21] . Previous studies have demonstrated that aortic aneurysms and cerebral artery pathologies are more prevalent in patients with autoimmune diseases compared with the general population, including rheumatoid arthritis, systemic lupus erythematosus and in Sjögren's syndrome. Several molecular mechanisms associated with the Sjögren's syndrome may participate in the onset and progression of aortic aneurysms and dissection thereby suggesting that the Sjögren's syndrome is associated with aortic disorders including aortitis and aneurysm [22] [23] [24] . There are some case reports in the literature relevant to Sjögren's syndrome and aortic disease [25, 26] . Clinical data from 10,941 patients and 43,764 control subjects extracted from Taiwan's National Health Insurance Research Database between 2000 and 2010 revealed that Sjögren's patients had significantly a higher prevalence of aortic aneurysm or dissection compared to controls (0.43% vs. 0.37%) after a follow-up period of ten years. Further analysis also disclosed that Sjögren's Case Report patients whether primary or secondary had a significantly higher risk of developing both aortic aneurysm and dissection in regard to control subjects [25] . These findings strongly suggest that Sjögren's patients have a higher risk of developing an aortic aneurysm and dissection. Although Sjögren's syndrome constitutes a risk factor for inflammatory artery disease relevant to aortic and cerebral arteries, there are no previous data in the literature reporting the presence of a splenic artery aneurysm in these patients. Our findings elicit that splenic artery aneurysm may occur in Sjögren's syndrome even if the clinical profile of the patient is silent or irrelevant that may lead to a fatal outcome if unidentified on time. The primary mechanism for the splenic artery aneurysm is probably the lymphocytic infiltration and the destruction of the vessel wall. The splenic artery aneurysm in this patient is due to the inflammatory arteritis that may be associated with the lymphocytic alveolitis of the lung both of which may have arisen from a common autoimmune pathway that has led to destructive lesions in various organs in the Sjögren's syndrome. Inflammatory lymphocytic interstitial inflammation has caused bronchiectasis along with fibrotic lesions in the lung while the perivascular lymphocytic infiltration may have precipitated the splenic artery aneurysm.
Conclusions
Splenic artery aneurysms are extremely rare. Diagnosis requires a high index of clinical suspicion as most of the patients are asymptomatic, clinically silent or present with symptoms irrelevant to the splenic artery aneurysm. Due to the high rate of mortality following an aneurysmatic rupture, identification of a splenic artery aneurysm is highly crucial. Although many different locations for aneurysmal dilatation including the aortic and cerebral arteries have been reported in Sjögren's syndrome, our case is the first in literature that reveals a splenic artery aneurysm in these patients. The clinicians should bear in mind that Sjögren's syndrome may constitute a risk factor for splenic artery aneurysm and such an occurrence may arise in the presence of an unusually silent clinical profile that may lead to a fatal outcome. The primary mechanism for the splenic artery aneurysm in our patient is probably the lymphocytic infiltration of the perivascular wall due to an autoimmune expedient of Sjögren's syndrome that has induced similar lesions in the lung parenchyma consisting of bronchiectasis with fibrotic lesions as a result of lymphocytic alveolitis. 
